{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:04:31Z","timestamp":1791043471809,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jviromet.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T00:35:29Z","timestamp":1337646929000},"page":"103-105","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV"],"prefix":"10.1016","volume":"184","author":[{"given":"Loretta","family":"Fiorina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Paolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Baldanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jviromet.2012.05.006_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.21030","article-title":"Viral hepatitis","volume":"43","author":"Alter","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/FTD.0b013e3180308554","article-title":"Analysis of ITPA phenotype\u2013genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6","volume":"29","author":"Atanasova","year":"2007","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhep.2006.09.019","volume":"46","author":"Akuta","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jviromet.2011.04.023","article-title":"HIV-1 nucleotide mixture detection in the virco\u00aeTYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencing","volume":"175","author":"De Wolf","year":"2011","journal-title":"Journal of Virological Methods"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08825","article-title":"ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C","volume":"464","author":"Fellay","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0035","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.20139","article-title":"Host factors and failure of interferonalpha treatment in hepatitis C virus","volume":"39","author":"Gao","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0045","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0050","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/gut.2003.031336","article-title":"Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences","volume":"53","author":"Pascu","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0055","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/hep.22543","article-title":"Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viraland host factors","volume":"48","author":"Shirakawa","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","article-title":"Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency","volume":"111","author":"Sumi","year":"2002","journal-title":"Human Genetics"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0065","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0080","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1053\/j.gastro.2010.06.016","article-title":"Variants in the ITPA gene protect against ribavirin-induced haemolytic anemia and decrease the need for ribavirin dose reduction","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0085","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.1840190505","article-title":"Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection","volume":"19","author":"Tsubota","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0090","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genesin patients with chronic Hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2012.05.006_bib0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.2005.069674","article-title":"Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1","volume":"55","author":"Walsh","year":"2006","journal-title":"Gut"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412001620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412001620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T09:56:30Z","timestamp":1542966990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093412001620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":19,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0166093412001620"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2012.05.006","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}